Prediction Models for Complications After CRT in Esophageal Cancer
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: retrospective.
- Кому может быть актуально
- Состояния в реестре: The Aim of This Project is to Develop and Validate NTCP-models for Complications After nCRT (and Surgical Resection). Базовые параметры: 18 лет — 100 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Нидерланды
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
The aim of this project is to develop and validate NTCP-models for complications after nCRT (and surgical resection), that can be uses for model-based dose optimization for PhRT and PRT, and for model-based selection for PRT, in patients with esophageal cancer
Подробное описание
Plan of investigation
In the present project we aim to evaluate two potential strategies to predict and consider a broad spectrum of complications for radiotherapy plan optimization and patient selection:
A comprehensive set of separate NTCP-models for several cardiopulmonary and post-operative complications after nCRT, which results in an NTCP-profile.
A single multivariable NTCP-model for a so-called Complication Sum Score (CSS), which is a single composite complication endpoint including all complications after nCRT, weighted depending on severity and impact.
These prediction models can be used for RT plan optimization and patient selection.
In order to develop these prediction models the project consortium brings together existing prospective data registries for esophageal cancer, namely the Dutch Upper GI Cancer Audit (DUCA) and the Dutch Cancer Registry (NKR) (as well as the POCOP study).
The data of these registries will be linked to a retrospective radiotherapy database using the ProTRAIT infrastructure, resulting in a dataset of over 2000 patients.
In this retrospective cohort study, we will focus on esophageal cancer patients who were treated with nCRT, and for whom an esophagectomy was intended. We will include the patients who received nCRT and the esophagectomy in one of the participating centers. Patients who only received nCRT in one of the participating centers and for whom surgical resection was omitted will be included as well. Detailed eligibility criteria can be found in that section.
Eligible patients will be identified by the Dutch Cancer Registry. The surviving patients will be asked to provide informed consent for participation in this study, permission to combine the different data registries and for future use of their data. Patients who died will be included as well, unless they objected agains the use of there data in the participating centers.
Of the participating patients, the radiotherapy plan-CT and treatment plans (i.e. RTplan, RT struct, RT dose), will be pseudo-anonymized, uploaded and transferred to the UMCG data platform, by the participating radiotherapy centers.
A third trusted party, Zorg TTP, will be responsible for the pseudonymization of the three data sources; the Dutch upper GI cancer audit (DUCA), the Dutch Cancer Registry (NKR) and the RTregistry. After that the linkage will be performed at the UMCG.
Вмешательства
- Другое retrospective
follow up
Первичные конечные точки
- Multivariable NTCP models will be developed for the prediction of the following [Срок оценки: Within 90 days after surgery]
- Cardiac events grade II or higher (CTCAE v 5.0), including: [Срок оценки: 1 and 2 year after nCRT]
- Mortality [Срок оценки: 1 and 2 year after nCRT]
- Complication Sum Score, that will be determined in Delphi consensus [Срок оценки: 1 year after nCRT]
Вторичные конечные точки (5)
- Patient-rated dysphagia [Срок оценки: Up to 30 days after nCRT]
- Patient-rated nausea [Срок оценки: Up to 30 day after nCRT]
- Patient-rated fatigue / daily functioning [Срок оценки: Up to 6 months after nCRT]
- Hospitalization after esophagectomy (days) [Срок оценки: Hospitalization after esophagectomy, average 12 days]
- Intensive care unit stay after esophagectomy (days) [Срок оценки: Intensive care unit stay after esophagectomy, average 1.5 days]
Критерии участия
Критерии включения
- Tumor in the esophagus, histologically proven or suspect for esophageal carcinoma
- WHO performance 0-2
- Age>18years
- No distant metastasis (M0)
- Treated with nCRT and planned for or followed by an esophagectomy between 2015 and 2021 in one of the participating centers.
Критерии исключения
- Sarcoma, neuro-endocrine or small cell carcinoma of the esophagus
- Patients who underwent a surgical resection in a non-participating surgical center will be excluded
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Дизайн исследования
- Модель наблюдения
- Другое
Центры проведения
Нидерланды · 8 центров
- Radboud UMC — Nijmegen
- Maastro clinic — Maastricht
- Amsterdam UMC — Amsterdam
- Erasmus MC — Rotterdam
- Holland PTC — Delft
- UMCG — Groningen
- Zuyderland hospital — Heerlen
- UMCU — Utrecht
Идентификаторы
NCT: NCT06366828 · 11446